Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Exelixis Inc., 3 years.
Exelixis Inc.
Director
Caris Life Sciences Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 29, 2026 | Caris Life Sciences Inc. | Grant or award | +1,600 | $15.62 | $24,992 |
| May 27, 2026 | Exelixis Inc. | Grant or award | +8,367 | — | — |
| May 7, 2026 | Exelixis Inc. | Open-market sale | −60,000 | $45.71 | $2,742,600 |
| Aug 11, 2025 | Caris Life Sciences Inc. | Option exercise | +125,000 | $2.44 | $305,000 |
| Aug 11, 2025 | Caris Life Sciences Inc. | Shares withheld for tax | −48,022 | $29.75 | $1,428,655 |
| Aug 11, 2025 | Caris Life Sciences Inc. | Shares withheld for tax | −91,495 | $29.75 | $2,721,976 |
| May 29, 2025 | Exelixis Inc. | Grant or award | +9,812 | — | — |
| May 16, 2025 | Exelixis Inc. | Option exercise | +20,634 | $19.77 | $407,934 |
| May 16, 2025 | Exelixis Inc. | Open-market sale | −20,634 | $45.99 | $948,958 |
| Feb 14, 2025 | Exelixis Inc. | Option exercise | +15,874 | $20.50 | $325,417 |
| Feb 14, 2025 | Exelixis Inc. | Open-market sale | −15,874 | $34.74 | $551,463 |
| Nov 1, 2024 | Exelixis Inc. | Open-market sale | −30,000 | $34.00 | $1,020,000 |
| Aug 8, 2024 | Exelixis Inc. | Open-market sale | −33,725 | $26.89 | $906,865 |
| May 31, 2024 | Exelixis Inc. | Grant or award | +18,838 | — | — |
| May 21, 2024 | Exelixis Inc. | Option exercise | +11,686 | $19.57 | $228,695 |
Questions about George Poste
What boards is George Poste on?
George Poste sits on the boards of Caris Life Sciences Inc. and Exelixis Inc.
How long has George Poste served on boards?
Our records show at least 5 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.